Your session is about to expire
← Back to Search
LASIK
Contoura with Phorcides and WaveLight Wavefront Optimized for Near-sightedness and Astigmatism
N/A
Recruiting
Research Sponsored by Daniel Terveen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-op
Awards & highlights
Study Summary
This trial compares two different types of LASIK surgery to see which one results in better vision and patient satisfaction.
Eligible Conditions
- Near-sightedness
- Astigmatism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-op
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-Op UDVA
Secondary outcome measures
Corrected Distance Visual Acuity
Low Contrast Visual Acuity
Post-OP BCVA
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Study: PhorcidesExperimental Treatment1 Intervention
Contoura with Phorcides used for surgical planning of LASIK procedure
Group II: Control: Wavefront OptimizedActive Control1 Intervention
WaveLight Wavefront Optimized used for surgical planning of LASIK procedure
Find a Location
Who is running the clinical trial?
Daniel TerveenLead Sponsor
Alcon ResearchIndustry Sponsor
704 Previous Clinical Trials
124,391 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had eye surgery in the past.You have a condition called strabismus or amblyopia.You are in good health overall, including your eyes.You cannot have LASIK surgery if you have severe dry eye, problems with your cornea, uncontrolled glaucoma, certain medical conditions like diabetes, or a history of herpes.You have a disease that affects your immune system.You are pregnant or currently breastfeeding.The study only includes participants with normal vision (no need for glasses) in both eyes.
Research Study Groups:
This trial has the following groups:- Group 1: Control: Wavefront Optimized
- Group 2: Study: Phorcides
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Might I qualify for inclusion in this research project?
"Aspiring participants of this clinical study must have myopia and be aged between 21 and 38. The trial is anticipating to enrol 120 patients."
Answered by AI
Are new participants being recruited for this experiment at the moment?
"According to information hosted on clinicaltrials.gov, this experiment is not seeking participants at the moment. The study was first listed on August 15th 2022 and had its last update a few weeks ago on the 1st of August 2022. Despite that, there are still 129 other studies currently recruiting individuals for their trials."
Answered by AI
Does the protocol for this trial encompass individuals older than seventy years?
"This research is enrolling individuals in the age group of 21 and 38 years old."
Answered by AI
Who else is applying?
What state do they live in?
South Dakota
What site did they apply to?
Vance Thompson Vision
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger